心臓移植(Heart Transplantation):治療薬開発パイプライン動向2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIPR2016277)
◆英語タイトル:Heart Transplantation-Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIPR2016277
◆発行日:2019年04月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[心臓移植(Heart Transplantation):治療薬開発パイプライン動向2018]についてメールでお問い合わせはこちら
※本調査レポートでは、世界における心臓移植(Heart Transplantation)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の薬剤リスト等をお届けしています。また、心臓移植(Heart Transplantation)治療薬開発に取り組んでいる企業情報も提供しています。

・心臓移植(Heart Transplantation)の概要

・心臓移植(Heart Transplantation)の治療薬パイプライン概要

・企業別開発中の心臓移植(Heart Transplantation)治療薬

・後期治験段階の薬剤(Filed & Phase III):比較分析

・中期治験段階の薬剤(Phase II):比較分析

・初期治験段階の薬剤(Phase I & IND Filed):比較分析

・前臨床段階の薬剤:比較分析

・薬剤候補のプロファイル

・心臓移植(Heart Transplantation)治療薬の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価

・開発が中止された薬剤リスト

・開発休止中の薬剤リスト

・心臓移植(Heart Transplantation)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “ Heart Transplantation-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Heart Transplantation. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Heart Transplantation. DelveInsight’s Report also assesses the Heart Transplantation therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitivepipeline landscape of Heart Transplantation
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Heart Transplantation pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Heart Transplantation and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Heart Transplantation Overview
• Heart Transplantation Pipeline Therapeutics
• Heart Transplantation Therapeutics under Development by Companies
• Heart Transplantation Filed and Phase III Products
• Comparative Analysis
• Heart Transplantation Phase II Products
• Comparative Analysis
• Heart Transplantation Phase I and IND Filed Products
• Comparative Analysis
• Heart Transplantation Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Heart Transplantation – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Heart Transplantation – Discontinued Products
• Heart Transplantation – Dormant Products
• Companies Involved in Therapeutics Development for Heart Transplantation
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Heart Transplantation, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Heart Transplantation Assessment by Monotherapy Products
• Heart Transplantation Assessment by Combination Products
• Heart Transplantation Assessment by Route of Administration
• Heart Transplantation Assessment by Stage and Route of Administration
• Heart Transplantation Assessment by Molecule Type
• Heart Transplantation Assessment by Stage and Molecule Type
• Heart Transplantation Therapeutics – Discontinued Products
• Heart Transplantation Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Heart Transplantation, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Heart Transplantation Assessment by Monotherapy Products
• Heart Transplantation Assessment by Combination Products
• Heart Transplantation Assessment by Route of Administration
• Heart Transplantation Assessment by Stage and Route of Administration
• Heart Transplantation Assessment by Molecule Type
• Heart Transplantation Assessment by Stage and Molecule Type


*** レポートのキーワード ***

心臓移植(Heart Transplantation)、治療薬、医薬品、薬剤、製薬企業、研究開発、治験、パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • NEPネットワークマネジメントシステムの世界市場2014–2018
    This report provides a 5-year forecast of spending in the network management systems (NMS) market. It discusses the capabilities of NMS that can help communications service providers (CSPs) to roll out new technologies and create new revenue streams. The report also considers the changes in NMS that …
  • 化学的・物理的分析装置(煙/ガス分析、電気泳動、分光光度計など)市場:アゼルバイジャン
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for chemical and physical analysis equipment in Azerbaijan. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable …
  • Terratec Asia Pacific Pty Ltd – 企業概要
    WMI's 'Terratec Asia Pacific Pty Ltd - Company Capsule' is a crucial resource for industry executives and anyone looking to access key information about 'Terratec Asia Pacific Pty Ltd '. WMI's 'Terratec Asia Pacific Pty Ltd - Company Capsule' report utilizes a wide range of primary and secondary sou …
  • パスタ及び麺(ヌードル)食品市場:グアム(~2017)
    Synopsis "Pasta and Noodles Market in Guam: Databook to 2017" is the result of Canadean's extensive market research covering the Pasta and Noodles market in Guam. The report presents detailed historic and forecast data on the Pasta and Noodles consumption trends in Guam, offering consumption volume …
  • 重クロム酸カリウムの世界及び中国市場 2018年
    The 'Global and Chinese Potassium Dichromate Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Potassium Dichromate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Potassium …
  • 南アフリカのインターネット接続市場
    The internet access market in South Africa has witnessed good growth in recent years with the market growing at a rate of over 60% in the year 2011 and went on to account for over $350 million worth in revenues. In the coming years, the South African internet access market is forecast to witness sub …
  • 注射用ミカファンギンナトリウムの世界市場予測2018-2023
    Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
  • Eranz:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2014
    Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of …
  • 世界の煙道ガス脱硫装置市場2017
    Flue Gas Desulfurizer Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United S …
  • UV硬化性アクリル系接着テープの世界市場:販売動向2017
    Notes:Sales, means the sales volume of UV-cured Acrylic Adhesive Tapes Revenue, means the sales value of UV-cured Acrylic Adhesive Tapes This report studies sales (consumption) of UV-cured Acrylic Adhesive Tapes in Global market, especially in United States, China, Europe and Japan, focuses on top p …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIPR2016277 )"心臓移植(Heart Transplantation):治療薬開発パイプライン動向2018" (英文:Heart Transplantation-Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。